Prospect Venture Partners Closes $500M Fund

Third Fund Dedicated to Life Science Investing   PALO ALTO, CA – Prospect Venture Partners, a venture capital firm dedicated to investing in medical technology and life science companies, today announced the closing of its third fund, Prospect Venture Partners III. The oversubscribed fund was closed at $500 million. The majority of investors represented returning […]

Prospect Venture Partners Closes $500M Fund

Prospect Venture Partners PALO ALTO, Calif., July 30 /PRNewswire/ — Prospect Venture Partners, a venture capital firm dedicated to investing in medical technology and life science companies, today announced the closing of its second fund, Prospect Venture Partners II. The oversubscribed fund was closed at $500 million.   The fund’s four Managing Partners are Alex […]

Pension Fund Makes Big Investment in Biotech

Silicon Valley Business Ink Bay Area biotech venture capitalists just got a $235 million shot in the arm from the California Public Employees Retirement System. In June CalPERS unveiled its $500 million California Biotechnology Program, a new venture for the state employees’ pension fund, and recently announced the firms that will receive the first round […]

New Bio-Med Fund Hits $100 Million Cap

Venture Capital Journal   PALO ALTO, Calif. — Prospect Venture Partners, a first-time effort by Kleiner Perkins Caufield & Byers alumni Alex Barkas and David Schnell, had such success in fund raising that the partners were bashful about acknowledging their success. The pair targeted their first fund at $75 million (VCJ, August 1997, page 8), […]